Treace to Report First Quarter 2025 Financial Results on May 8, 2025 | TMCI Stock News

Apr 24, 2025

Treace Medical Concepts (TMCI, Financial) to announce Q1 2025 financial results on May 8, 2025.
Conference call scheduled at 4:30 pm ET on the same day to discuss results.
Investors can access the live and archived webcast on the company's investor relations site.

Treace Medical Concepts, Inc. (TMCI), a leader in the medical technology sector focusing on bunion and midfoot deformity surgical treatments, has announced that it will release its financial results for the first quarter of 2025 after market close on May 8, 2025. The announcement will be followed by a conference call held by the company management starting at 4:30 pm ET.

Investors interested in participating in the call can register to receive the necessary dial-in numbers and a unique pin. The event will also feature a live and archived webcast available on Treace Medical's investor relations website at https://investors.treace.com/.

Treace Medical is renowned for its flagship Lapiplasty® 3D Bunion Correction System and Adductoplasty® Midfoot Correction System, which seek to address the root causes of bunion and midfoot deformities effectively. The company continues to innovate in the foot and ankle market, aiming to revolutionize treatment options for bunion patients.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.